PHOSVEDA Trademark

Trademark Overview

On Tuesday, June 3, 2014, a trademark application was filed for PHOSVEDA with the United States Patent and Trademark Office. The USPTO has given the PHOSVEDA trademark a serial number of 86298761. The federal status of this trademark filing is REGISTERED AND RENEWED as of Sunday, July 14, 2024. This trademark is owned by BioLink Life Sciences, Inc.. The PHOSVEDA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, calcium succinate
phosveda

General Information

Serial Number86298761
Word MarkPHOSVEDA
Filing DateTuesday, June 3, 2014
Status800 - REGISTERED AND RENEWED
Status DateSunday, July 14, 2024
Registration Number4675020
Registration DateTuesday, January 20, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 4, 2014

Trademark Statements

Goods and Servicespharmaceutical preparations, namely, calcium succinate

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 17, 2014
Primary Code005
First Use Anywhere DateThursday, January 2, 2014
First Use In Commerce DateThursday, January 30, 2014

Trademark Owner History

Party NameBioLink Life Sciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCary, NC 27513
Party NameBioLink Life Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCary, NC 27513
Party NameBioLink Life Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCary, NC 27513

Trademark Events

Event DateEvent Description
Monday, September 15, 2014ASSIGNED TO EXAMINER
Tuesday, June 17, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 16, 2014EXAMINER'S AMENDMENT ENTERED
Tuesday, September 16, 2014EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 16, 2014EXAMINERS AMENDMENT E-MAILED
Tuesday, September 16, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 16, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 30, 2014ASSIGNED TO LIE
Tuesday, September 30, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 15, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 4, 2014PUBLISHED FOR OPPOSITION
Tuesday, November 4, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 20, 2015REGISTERED-PRINCIPAL REGISTER
Monday, January 20, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, February 6, 2020TEAS SECTION 8 & 15 RECEIVED
Thursday, April 2, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, April 2, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, April 2, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, January 20, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, April 17, 2024TEAS SECTION 8 & 9 RECEIVED
Sunday, July 14, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, July 14, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sunday, July 14, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sunday, July 14, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

phosveda succinate calcium namely preparations pharmaceutical